Compare · ALGN vs HSCS
ALGN vs HSCS
Side-by-side comparison of Align Technology Inc. (ALGN) and HeartSciences Inc. (HSCS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALGN and HSCS operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ALGN is the larger of the two at $12.66B, about 1477.7x HSCS ($8.6M).
- Over the past year, ALGN is down 6.6% and HSCS is down 29.0% - ALGN leads by 22.5 points.
- ALGN has been more active in the news (5 items in the past 4 weeks vs 3 for HSCS).
- ALGN has more recent analyst coverage (25 ratings vs 0 for HSCS).
- Company
- Align Technology Inc.
- HeartSciences Inc.
- Price
- $176.69-0.99%
- $2.85+14.00%
- Market cap
- $12.66B
- $8.6M
- 1M return
- -1.56%
- +58.33%
- 1Y return
- -6.56%
- -29.02%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2001
- 2022
- News (4w)
- 5
- 3
- Recent ratings
- 25
- 0
Align Technology Inc.
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Latest ALGN
- Operation Smile Announces Align Technology as Title Sponsor of 34th International Student Leadership Conference for Sixth Year
- BMO Capital Markets initiated coverage on Align Tech with a new price target
- Align Technology Inc. filed SEC Form 8-K: Leadership Update
- Align Technology to Announce Second Quarter 2026 Results on July 29, 2026
- Align Technology Statement on European Commission Proceeding
- Align Technology Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Align Technology Announces Board Leadership Transition. C. Raymond Larkin, Jr. to Retire as Chairman and Kevin Conroy to be Appointed Chairman Effective July 1, 2026
- Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research
- SEC Form SD filed by Align Technology Inc.
- Director Vitalone Britt J. converted options into 1,443 shares (SEC Form 4)
Latest HSCS
- SEC Form DEFA14A filed by HeartSciences Inc.
- HeartSciences Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- SEC Form 4 filed by Officer Watson Danielle
- SEC Form DEFA14A filed by HeartSciences Inc.
- HeartSciences Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- SEC Form DEFA14A filed by HeartSciences Inc.
- SEC Form DEFA14A filed by HeartSciences Inc.
- SEC Form DEFA14A filed by HeartSciences Inc.
- Officer Simpson Andrew was granted 425,000 shares, increasing direct ownership by 571% to 499,382 units (SEC Form 4)
- SEC Form DEFA14A filed by HeartSciences Inc.